India Diabetes Devices Market - Growth, Trends, and Forecast (2019 - 2024)

The Market is segmented by Management Devices (Insulin Pumps, Insulin Pens, Syringes, and Cartridges) and Monitoring Devices (Self-monitoring Blood Glucose (Hospital and Personal Use) and Continuous Glucose Monitoring).

Market Snapshot

India Diabetes Devices
Study Period:

2012-2024

Base Year:

2018

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

  • The Indian diabetes devices market has been estimated at USD 0.8 billion in 2019, registering a CAGR of 1.46% during the forecast period from 2019 to 2024. 
  • Diabetes care devices are the devices used to control the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. 
  • The continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations.
  • India holds the second-largest market in the diabetes care devices market after China in the Asia-Pacific region, because of the high diabetes population in the country. The diabetes population is also expected to reach 85.9 million in 2024 in India.

Scope of the Report

The Market is segmented by management devices (insulin pumps, insulin pens, syringes, and cartridges) and monitoring devices (self-monitoring blood glucose (hospital and personal use) and continuous glucose monitoring).

By Monitoring Devices Self-monitoring Blood Glucose Glucometer Devices Hospital
Personal
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors  
Receivers  
By Management Devices Insulin Pump Insulin Pump Device  
Insulin Pump Reservoir  
Infusion Set  
Insulin Syringes    
Cartridges in Reusable pens    
Insulin Disposable Pens    

Key Market Trends

The use of Monitoring devices in India is increasing

  • Monitoring devices include self-monitoring blood glucose (SMBG) and continuous glucose monitoring devices (CGM), where SMBG segment of the market studied has the highest share in the year 2018, with a revenue of USD 0.1 billion. 
  • The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. 
  • The awareness of self-monitoring of glucose levels has increased widely in India, and the market of the whole monitoring devices is expected to see high growth in the country with a CAGR of 10% by 2024.
  • Type-1 diabetic patients need to check their blood glucose levels at regular intervals to monitor their blood glucose levels and adjust the insulin dosing accordingly.
  • The current CGM devices reduce all the finger pricking for measuring blood glucose levels. It shows a detailed representation of blood glucose patterns and tendencies than what can be achieved by conventional routine checking of glucose levels at set intervals. 
India Diabetes Devices_Key trend 1

To understand key trends, Download Sample Report

India has the Highest Number of Diabetes population next to China.

  • With 50.8 million people suffering from diabetes, India continues to be the ‘diabetes capital.’ By 2030, nearly 9% of India’s population is likely to be affected by diabetes, according to a study conducted by the International Diabetes Federation.
  • Obesity, especially central obesity and increased visceral fat due to physical inactivity, and consumption of a high-calorie/high-fat and high sugar diets, are the major contributing factors for diabetes in Indians.
  • The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.
India Diabetes Devices_Key trend 2

Competitive Landscape

Indian diabetes devices market is highly consolidated, with a few significant players. Abbott’s new FreeStyle Libre Flash Glucose Monitoring System was approved, which is the first continuous blood sugar monitor for people with diabetes that does not need backup finger prick tests. The innovations in test strips are increasing and are under development. For example, the new test strip includes features, such as underfill detection, and provides the user with the ability to reapply blood when the test strip is underfilled (“second chance” sampling). 
 

Major Players

  1. Medtronics
  2. Becton Dickinson
  3. Roche
  4. Dexcom
  5. Abbott

* Complete list of players covered available in the table of contents below

India Diabetes Devices

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Product

      1. 5.1.1 By Monitoring Devices, Value and Volume (2012-2024)

        1. 5.1.1.1 Self-monitoring Blood Glucose

          1. 5.1.1.1.1 Glucometer Devices

            1. 5.1.1.1.1.1 Hospital

            2. 5.1.1.1.1.2 Personal

          2. 5.1.1.1.2 Blood Glucose Test Strips

            1. 5.1.1.1.2.1 Hospital

            2. 5.1.1.1.2.2 Personal

          3. 5.1.1.1.3 Lancets

            1. 5.1.1.1.3.1 Hospital

            2. 5.1.1.1.3.2 Personal

        2. 5.1.1.2 Continuous Glucose Monitoring

          1. 5.1.1.2.1 Sensors

          2. 5.1.1.2.2 Receivers

      2. 5.1.2 By Management Devices, Value and Volume (2012-2024)

        1. 5.1.2.1 Insulin Pump

          1. 5.1.2.1.1 Insulin Pump Device

          2. 5.1.2.1.2 Insulin Pump Reservoir

          3. 5.1.2.1.3 Infusion Set

        2. 5.1.2.2 Insulin Disposable Pens

        3. 5.1.2.3 Insulin Syringes

    2. 5.2 Geography

      1. 5.2.1 India

        1. 5.2.1.1 Monitoring Devices (Value and Volume, 2012-2024)

        2. 5.2.1.2 Management Devices (Value and Volume, 2012-2024)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Becton and Dickenson

    2. 6.2 Medtronic

    3. 6.3 Insulet

    4. 6.4 Tandem

    5. 6.5 Ypsomed

    6. 6.6 Novo Nordisk

    7. 6.7 Sanofi

    8. 6.8 Eli Lilly

    9. 6.9 Abbottt

    10. 6.10 Roche

    11. 6.11 Lifescan (Johnson &Johnson)

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information